# An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

> **NCT01398956** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 44 (actual)

## Conditions studied

- Epilepsy
- Generalized Tonic-clonic Seizures

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT01398956
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01398956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01398956, "An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01398956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*